key: cord-0071988-c9g6eqtd
authors: Nojomi, Marzieh; Moradi-Lakeh, Maziar; Pourmalek, Farshad
title: COVID-19 in Iran: What was done and what should be done
date: 2021-07-29
journal: Med J Islam Repub Iran
DOI: 10.47176/mjiri.35.97
sha: 3aa3d3d8de724f121f698739e3b39776651dcfb0
doc_id: 71988
cord_uid: c9g6eqtd

The current COVID-19 pandemic started in Wuhan, China, in December 2019. The World health Organization (WHO) declared the COVID-19 as a public health emergency of international concern on January 30, 2020, and recognized the situation as a pandemic on March 11, 2020. Around 135 million confirmed cases and around 2.9 million deaths until the first week of April 2021 have been among its direct impacts on human health. All countries have been affected in different degrees, and each of them has used different strategies to protect themselves against health and nonhealth consequences of this epidemic. Although all approaches are full of mistakes with fatal and painful results, some of them were successful in limiting the epidemic. One of the astonishing improvements is development of several vaccines in a relatively short period of time, which has increased hopes for epidemic control. This review aims to critically appraise the strategies for COVID-19 epidemic control in Iran since the beginning of the disease until the fourth peak of disease in March 2021.

-CoV-2 starte 1). The disea COVID-19, RS). The Wo COVID-19 a l concern on se as a pandem g the pandem ave been repo and territorie f these cases, 

WHO Direct COVID-19-1 2020. Retrieve 4. Case-Fatality risk-covid

Covid-19 s Switzerland, 1 covid-19-strate 12. The decisio (CNAVH) ar

Screening of of Corona